{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifiynawpcfwmakh5sdd4kv7q5n2dkwt7qlnhm2r52vfbfgdcrtvrq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3movu67iuxip2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieloetnnh46ftwza354lbgyun7brkc5nsmzc6e745krgkjf6itium"
    },
    "mimeType": "image/jpeg",
    "size": 63054
  },
  "path": "/2026/06/22/pfizer-lung-cancer-sigvotatug-vedotin/?utm_campaign=rss",
  "publishedAt": "2026-06-22T21:36:11.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "biotechnology",
    "Cancer",
    "drug development",
    "Pfizer",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "Pfizer said an experimental drug it hoped could replace a widely used chemotherapy in one of the most common forms of lung cancer fell short in a clinical trial.",
  "title": "STAT+: Closely watched Pfizer lung cancer drug falls short in clinical trial",
  "updatedAt": "2026-06-22T21:36:15.000Z"
}